ImpediMed (ASX:IPD) is a medical technology company that develops, manufactures, and sells bioimpedance spectroscopy devices and software for the diagnosis and monitoring of chronic diseases, such as lymphedema, heart failure, and liver disease. ImpediMed's devices and software are used by clinicians and patients in over 50 countries. ImpediMed's operations are focused on the development, manufacturing, and sale of its BIS devices and software. The company has a team of experienced engineers and scientists who are responsible for the development of its products. ImpediMed also has a team of sales and marketing professionals who are responsible for selling and marketing its products to clinicians and patients around the world.